Jun 27, 2022
One Day in-person Meeting 27 September 2022, Basel
One Day in-person Meeting 27 September 2022, Basel
Submit your paper ideas by: 5th July 2022
This one day meeting will offer just 100 delegate places - register as soon as registration opens to secure your place.
Jan 13, 2022
Last month we published our December News and so why not tak
Jan 11, 2022
EPHMRA Webinar - Social Listening in Pharma.
After a well-attended webinar in November we are bringing this event to you again in 2022.
Join us on 1st February 2022 at 14.15 UK time with guest speaker; Yannick Rieder, Market Research & Competitive Intelligence Manager, Janssen-Cilag GmbH and Convenor; An-hwa Lee, Director at Research Partnership and member of the LDC.
Jan 10, 2022
Happy New Year
...to all EPHMRA colleagues and member companies. Hope you all have a very good 2022 and stay safe and well.
It’s been a challenging past 12 months but let's get 2022 off to the best start we can!
Jan 10, 2022
EPHMRA March 2022 News
Contributions by 15 January please. For our March Newsletter please do send us your company news, this can be about people or services you would like to announce. We produce our news in PDF format for the web site and we have over 2500 contacts on our international healthcare market research database.
Jan 10, 2022
MR Excellence Awards 2022
Submissions for the MR Excellence awards are to be submitted by 28 February. EPHMRA is delighted to announce the launch of the EPHMRA MR Excellence Awards for 2022 in recognition of the amazing work our members and colleagues do.
Dec 14, 2021
Take a look at our December News update just published.
Find out more here
The News features articles from member companies:
1. Making the Healthy Habits Stick – Borderless Access
2. Virtual vs. in-person research: In defence of a hybrid approach – Branding Science
Sep 20, 2021
Take a look at the eNews advertising opportunities with ephmra
Sep 15, 2021
Here's a great resource from ADM in Germany - to support those working in our industry: https://www.adm-ev.de/en/standards-guidelines/#anker2
Sep 08, 2021
These guidelines provide the principal requirements of Pharmacovigilance (PV) reporting for individuals or organisations involved in market research (MR) activities within the healthcare industry. This includes those working for a Marketing Authorisation Holder (MAH), Market Research Organisation (MRA) or other organisations involved in MR activities. It applies to employees and contractors working with or for a MAH, MRA or other organisations engaged in MR.